Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
38.5M
-
Number of holders
-
70
-
Total 13F shares, excl. options
-
31.5M
-
Shares change
-
+31.5M
-
Total reported value, excl. options
-
$1.04B
-
Value change
-
+$1.04B
-
Number of buys
-
70
-
Price
-
$32.91
Significant Holders of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) as of Q1 2021
70 filings reported holding BOLT - Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share as of Q1 2021.
Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.5M shares
of 38.5M outstanding shares and own 81.78% of the company stock.
Largest 10 shareholders include Novo Holdings A/S (4.5M shares), Vivo Capital, LLC (3.87M shares), CITADEL ADVISORS LLC (2.92M shares), FMR LLC (2.88M shares), Sofinnova Investments, Inc. (2.75M shares), RA CAPITAL MANAGEMENT, L.P. (2.38M shares), Pivotal bioVenture Partners Investment Advisor LLC (1.89M shares), Rock Springs Capital Management LP (1.56M shares), BlackRock Inc. (839K shares), and Samsara BioCapital, LLC (737K shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.